SCHEMBL2653601

SCHEMBL2653601

N#Cc1c(NC(=O)C2CCCCC2)sc(-c2ccccc2)c1Cl

nearest known ligand 0.66

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.66
▸ NPC1 O15118 2/20 0.66
▸ RAB9A P51151 2/20 0.66
▸ SMN1; SMN2 Q16637 2/20 0.66
▸ CYP1A2 P05177 1/20 0.66
▸ CYP3A4 P08684 1/20 0.66
▸ CYP2D6 P10635 1/20 0.66
▸ CYP2C9 P11712 1/20 0.66
▸ CYP2C19 P33261 1/20 0.66
▸ ADORA1 P30542 5/20 0.54
▸ ADORA2A P29274 4/20 0.54
▸ HPGD P15428 2/20 0.52
▸ MAPT P10636 1/20 0.52
▸ GAA P10253 1/20 0.47
▸ ADORA3 P0DMS8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2655830 0.90 ALDH1A1 (0.70) ALDH1A1NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL2653131 0.86 ALDH1A1 (0.66) ALDH1A1NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL2656265 0.83 ALDH1A1 (0.61) ALDH1A1NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL2653851 0.74 SMN1; SMN2 (0.59) ALDH1A1NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL11474504 0.73 NPC1 (0.55) ALDH1A1NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL2644504 0.70 ALDH1A1 (0.97) ALDH1A1NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL1847935 0.70 ADORA2A (0.62) ALDH1A1NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL2649911 0.70 ALDH1A1 (0.57) ALDH1A1NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL2754027 0.69 ADORA1 (0.63) ALDH1A1SMN1; SMN2ADORA1ADORA2AHPGD
SCHEMBL1848064 0.68 ADORA2A (0.63) ALDH1A1NPC1RAB9ASMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1807411-A1 CYANOTHIOPHENES, THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS Boehringer Ingelheim International GmbH (DE) 2007-07-18 — — EP claimed
US-20060094764-A1 Cyanothiophenes, their preparation and their use in pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-05-04 — — US claimed
WO-2006042850-A1 CYANOTHIOPHENES, THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-04-27 — — WO claimed
EP-1807411-A1 CYANOTHIOPHENES, THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS Boehringer Ingelheim International GmbH (DE) 2007-07-18 — — EP disclosed
US-20060094764-A1 Cyanothiophenes, their preparation and their use in pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-05-04 — — US disclosed
WO-2006042850-A1 CYANOTHIOPHENES, THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-04-27 — — WO disclosed
WO-2006042850-A1 CYANOTHIOPHENES, THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-04-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094764-A1 Cyanothiophenes, their preparation and their use in pharmaceutical compositions GLRB, GPR6, GRM3 ALDH1A1 3592/4885NPC1 2475/4885RAB9A 3107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback